Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 1631 composition records across product categories including Cleaning and safety, Industrial products, Construction and building materials.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of MICROCRYSTALLINE CELLULOSE in our catalog (epa_cpdat).
Products
1,631
Brands
6
Typical roles
Catalog
Co-occurrence
Ingredients that frequently appear alongside MICROCRYSTALLINE CELLULOSE in the catalog.
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 1631 composition records across product categories including Cleaning and safety, Industrial products, Construction and building materials. EPA CPDat classifies this chemical for functional uses including Abrasive, Absorbent, Emulsifier.
US
FDA
Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 18 mg
US
FDA
SVR Spray Sun Secure SPF 50+
SVR
Route: INTRAVITREAL; Dosage form: IMPLANT; Potency: 1.66 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 2169 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Maximum daily exposure: 456 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 366 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 1246 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 29520 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, DELAYED RELEASE; Potency: 789.6 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 278 mg
US
FDA
Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 1140 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 690 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 4441 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 1600 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 1120 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 5117 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 1725 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 144 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 920 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 2210 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE PARTICLES; Maximum daily exposure: 580 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 5119 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 992 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 615 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 20100 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 1800 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 1576 mg
US
FDA
Route: ORAL; Dosage form: TROCHE; Maximum daily exposure: 300 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Potency: 43.2 mg
US
FDA
Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: NA
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 2430 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 1600 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 1582 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: NA
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 40.2 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 16 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 156 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 392 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Potency: 4.5 mg
US
FDA
FDA NDC lists this ingredient in 1 active drug products and 1 total products.
US
FDA
FDA NDC lists this ingredient in 1 active drug products and 4 total products.
US
FDA
openFDA substance registry classifies this ingredient as polymer.
US
FDA
openFDA substance registry classifies this ingredient as concept.